Cancer Innovation

Course Overview

The MRes Cancer Innovation at Imperial College London is a postgraduate programme designed for postgraduate students passionate about understanding living systems. Based in Hammersmith and Fulham, England, this Russell Group university offers a research-led approach to learning, with a 1-year full-time structure. Develop skills across disciplines to further your proficiency of experimental and computational research, and push forward research in cancer biology. In this Cancer Innovation stream, you will focus on the development of novel, innovative approaches to biological and medical problems in cancer. Blended learning with demonstrations and workshops will train you in the translation of biotechnology platforms, from concept to realisation and onward to application in the clinical/commercial environment. A minimum ielts score of 6.5 is required for admission. Graduates from this programme benefit from strong career prospects, with 90% student satisfaction rating, a median graduate salary of £33,000 within three years, and a 95% continuation rate.

What You'll Learn

Tuition Fees & Funding

Fees shown are for current entry. Fees may increase annually in line with inflation.

Graduate Outcomes

Frequently Asked Questions